DE3781185D1 - Peptid-derivate und methode zur messung der wirksamkeit von physiologisch aktiven verbindungen, die dieselben als substraten benuetzen. - Google Patents

Peptid-derivate und methode zur messung der wirksamkeit von physiologisch aktiven verbindungen, die dieselben als substraten benuetzen.

Info

Publication number
DE3781185D1
DE3781185D1 DE8787104767T DE3781185T DE3781185D1 DE 3781185 D1 DE3781185 D1 DE 3781185D1 DE 8787104767 T DE8787104767 T DE 8787104767T DE 3781185 T DE3781185 T DE 3781185T DE 3781185 D1 DE3781185 D1 DE 3781185D1
Authority
DE
Germany
Prior art keywords
physiologically active
effectiveness
substrates
measuring
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787104767T
Other languages
English (en)
Other versions
DE3781185T2 (de
Inventor
Tokuji Ikenaka
Tomohiro Mega
Yasuki Hamazume
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Wako Pure Chemical Corp
Original Assignee
Wako Pure Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wako Pure Chemical Industries Ltd filed Critical Wako Pure Chemical Industries Ltd
Publication of DE3781185D1 publication Critical patent/DE3781185D1/de
Application granted granted Critical
Publication of DE3781185T2 publication Critical patent/DE3781185T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/802—Chromogenic or luminescent peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyridine Compounds (AREA)
DE8787104767T 1986-04-01 1987-03-31 Peptid-derivate und methode zur messung der wirksamkeit von physiologisch aktiven verbindungen, die dieselben als substraten benuetzen. Expired - Lifetime DE3781185T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7634986 1986-04-01

Publications (2)

Publication Number Publication Date
DE3781185D1 true DE3781185D1 (de) 1992-09-24
DE3781185T2 DE3781185T2 (de) 1993-03-04

Family

ID=13602877

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787104767T Expired - Lifetime DE3781185T2 (de) 1986-04-01 1987-03-31 Peptid-derivate und methode zur messung der wirksamkeit von physiologisch aktiven verbindungen, die dieselben als substraten benuetzen.

Country Status (7)

Country Link
US (1) US5120644A (de)
EP (1) EP0240914B1 (de)
JP (1) JP2627503B2 (de)
AT (1) ATE79635T1 (de)
DE (1) DE3781185T2 (de)
ES (1) ES2051702T3 (de)
GR (1) GR3006172T3 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK93990D0 (da) * 1990-04-17 1990-04-17 Carlsberg As Fluorogene peptider og deres anvendelse ved bestemmelse af enzymatisk aktivitet
JPH07501444A (ja) * 1991-11-12 1995-02-16 プロメガ コーポレイション 非放射性酵素検定
CA2109646C (en) * 1992-11-24 2000-03-07 Gaston O. Daumy Para-nitroanilide peptides
US6348310B1 (en) 1994-03-04 2002-02-19 Promega Corporation Quantitation of individual protein kinase activity
US5527688A (en) * 1994-04-08 1996-06-18 Pierce Chemical Company Rapid assays for protein kinase activity
US5622830A (en) * 1994-12-12 1997-04-22 Daumy; Gaston O. Method of identifying interleukin 1β converting enzyme inhibitors
US6054557A (en) * 1995-04-04 2000-04-25 Advanced Bioconcept (1994) Ltd. Fluorescent peptides
BR9608776A (pt) * 1995-05-19 2000-10-24 New York Blood Ct Inc Processo de uso de ftalocianinas para inativar parasitas do sangue
US6821952B1 (en) 1995-07-20 2004-11-23 Perkinelmer Las, Inc. Fluorescent vasoactive intestinal peptide (VIP)
US20030036106A1 (en) * 1996-10-28 2003-02-20 Burke Thomas J. Kinase and phosphatase activity measurement using fluorescence polarization
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US7745142B2 (en) 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US6133297A (en) * 1997-09-30 2000-10-17 Merck & Co., Inc. Thrombin inhibitors
JP2001518466A (ja) * 1997-09-30 2001-10-16 メルク エンド カムパニー インコーポレーテッド トロンビン阻害薬
JP3015886B1 (ja) * 1998-11-04 2000-03-06 農林水産省食品総合研究所長 植物由来アスパラギン残基特異的エンドプロテアーゼ活性の迅速定量法
US20020123068A1 (en) * 2001-01-31 2002-09-05 Dwyer Brian P. Water-soluble, fluorescent, & electrophoretically mobile peptidic substrates for enzymatic reactions and methods for their use in high-throughput screening assays
KR20030084133A (ko) * 2002-04-25 2003-11-01 주식회사 아트만 바이오 사이언스 피디케이1 단백질 인산화효소 활성측정용 형광표지 펩티드및 이를 이용한 비방사성 피디케이1 단백질 인산화효소활성측정법
US7195884B2 (en) * 2002-07-19 2007-03-27 Promega Corp. Methods and kits for transferases
KR20040009726A (ko) * 2002-07-25 2004-01-31 주식회사 아트만 바이오 사이언스 아이엘케이1 단백질 인산화효소 활성측정용 형광표지펩티드 및 이를 이용한 비방사성 아이엘1 단백질인산화효소 활성측정법
US7619059B2 (en) 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
CA2538797A1 (en) * 2003-09-12 2005-03-24 Invitrogen Corporation Multiplex binding and activity assays
WO2012159079A1 (en) 2011-05-18 2012-11-22 The Parkinson's Institute Assay to determine lrrk2 activity in parkinson's disease

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB784181A (en) * 1954-09-10 1957-10-02 Bayer Ag Heterocyclic quinone derivatives
US4251628A (en) * 1978-03-14 1981-02-17 Ryan James W Substrates for angiotensin converting enzyme
IL60888A (en) * 1978-06-16 1984-07-31 Yeda Res & Dev Substrates and process for the quantitative assay of enzymes
US4275153A (en) * 1978-08-03 1981-06-23 American Hospital Supply Corporation Analytical fluorogenic substrates for proteolytic enzymes
US4409140A (en) * 1979-04-23 1983-10-11 Smith Robert E Substrates and method for determining enzymes
US4327178A (en) * 1979-05-01 1982-04-27 University Of Miami Urinary kallikrein assay: specific substrates and assay method
AT369033B (de) * 1981-02-02 1982-11-25 Immuno Ag Verfahren zur bestimmung der c1-esterase-inhibitor-aktivitaet von c1-esterase-inhibitor-haeltigen proben
IE54551B1 (en) * 1982-01-22 1989-11-22 Ici Plc Amide derivatives
DE3211932A1 (de) * 1982-03-31 1983-10-13 Hoechst Ag, 6230 Frankfurt Chromophore peptide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung zum nachweis von dd-carboxypeptidasen
US4505852A (en) * 1982-11-29 1985-03-19 Enzyme Systems Products 7-Amino-4-trifluoromethylquinolone derived substrates and method for determining enzymes and inhibitors
US4507389A (en) * 1982-12-16 1985-03-26 Monsanto Company Determination of collagenase by reacting with peptide substrates
US4557862A (en) * 1983-10-28 1985-12-10 University Patents, Inc. Rhodamine derivatives as fluorogenic substrates for proteinases
HU192914B (en) * 1985-02-11 1987-07-28 Richter Gedeon Vegyeszet Process for producing new 3-/substituted amino/-5-phenyl-2/3h/-furanone derivatives and pharmaceutically acceptable salts
US4812409A (en) * 1986-01-31 1989-03-14 Eastman Kodak Company Hydrolyzable fluorescent substrates and analytical determinations using same

Also Published As

Publication number Publication date
US5120644A (en) 1992-06-09
EP0240914A2 (de) 1987-10-14
EP0240914B1 (de) 1992-08-19
GR3006172T3 (de) 1993-06-21
DE3781185T2 (de) 1993-03-04
JPS6366197A (ja) 1988-03-24
JP2627503B2 (ja) 1997-07-09
EP0240914A3 (en) 1989-02-08
ES2051702T3 (es) 1994-07-01
ATE79635T1 (de) 1992-09-15

Similar Documents

Publication Publication Date Title
DE3781185D1 (de) Peptid-derivate und methode zur messung der wirksamkeit von physiologisch aktiven verbindungen, die dieselben als substraten benuetzen.
FI905925A0 (fi) Heteropolyhapon vaikealiukoisen suolan käyttö analyytin määritykseen, vastaava määritysmenetelmä sekä tähän sopiva aine
LU90155I2 (fr) Vistide - cidofovir 75 mg/ml
NO905608L (no) Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater.
ATE126436T1 (de) Antagonisten von exzitatorischen aminosäuren.
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
ATE112279T1 (de) Cc-1065 analoge.
ATE198335T1 (de) Cc-1065-analoge mit zwei cpi-subeinheiten
ES2110414T3 (es) Derivados de sacarina utiles como inhibidores de enzimas proteoliticas y su preparacion.
DK0559079T3 (da) Substituerede aminophosphonatderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
LV10108A (lv) Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni
ATE44621T1 (de) Proteinkonjugate von penicillosaeure, ihre herstellung und verwendung.
FI97152C (fi) Fluorogeenisia tryptofanaasisubstraatteja
Subramani et al. Ligand-promoted weakening of intersubunit bonding domains in aspartate transcarbamoylase
IT1216104B (it) Peptidi ad attivita' farmaceutica.
ATE149354T1 (de) Pharmazeutische zusammensetzung von stabilisiertem (leu 13>-motilin-hse
BRPI0407573A (pt) derivados de imidazo(4,5-b)quinolina e seu emprego como inibidores de sintase de no
DE69723456D1 (de) 1-(3-aminoindazol-5-yl)-3-phenylmethyl cyclische harnstoffe und ihre verwendung als hiv protease inhibitoren
DK0578535T3 (da) Hidtil ukendt peptid-derivater, der er aktive i celleadhæsionsprocesser, fremgangsmåde til deres fremstilling samt farmaceutiske sammensætninger indeholdende derivarerne
DE68909451D1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FR2574798B1 (fr) Nouvelle adenosine substituee en n6 et medicament la contenant comme principe actif

Legal Events

Date Code Title Description
8364 No opposition during term of opposition